Syenza News — health technology assessment, market access and health economics
AI operating room scheduling: LLM agent teams reach feasible plans
How can AI-powered scheduling transform operating room efficiency and deliver major cost savings?
Recent advancements are enabling hospitals to optimize resource allocation, reduce cancellations, and streamline workflows through intelligent automation.
Discover how this technology is reshaping surgical operations and improving financial outcomes.
#SyenzaNews #AIinHealthcare #HealthcareInnovation #ai #DigitalTransformation
Recent Posts
Most favored nation drug pricing: why US patient groups push back
Oct 16
FDA Rare Disease Framework Initiative Would Tailor Review to Small Populations
Oct 15
Semaglutide for Opioid Use Disorder: $13.3M Trial Planned in Allegheny County
Oct 15
AI guidance in clinical development: what industry is asking for
Oct 15
Social prescribing in Portugal: pilots, gaps and the cost of time
Oct 15Syenza's Top Picks
European medtech industry 2026: patents rise, market share slips
Oct 7, 2026
Uptake of New Cancer Medicines in Europe Still Varies
Oct 9, 2026
EpiScreen epilepsy detection model beats specialists on routine clinical notes
Oct 9, 2026
FDA Grants Rhapsido First Symptomatic Dermographism Approval
Oct 8, 2026
FuturePHARMA Targets Local Pharmaceutical Manufacturing in South Africa
Oct 8, 2026
PhRMA’s GLOBE Drug Pricing Lawsuit Seeks to Block the Medicare Rule
Oct 8, 2026
Latest News
Innovative Medicines And Medical Devices
EMA Expert Panel Consultation for Medical Devices Adds an Orphan Pathway
EMA has updated its business process for expert panel consultations on high-risk medical devices. The revision, effective 12 October 2026, adds orphan device advice as a new sub-process. #SyenzaNews #MedicalDevices #MarketAccess #HTA
Clinical Practice
BNT113 head and neck cancer trial misses first endpoint
BioNTech’s AHEAD-MERIT trial did not reach significance on progression-free survival. The overall survival read-out is still to come.
Cost Effectiveness Analysis
Rapid-Acting Insulin Analogue Cost-Effectiveness in Type 1 Diabetes: What the Evidence Shows
Insulin analogue cost-effectiveness studies for adults with type 1 diabetes mostly point the same way: the newer products usually come out ahead of human insulin. A new systematic review says that headline rests on thinner ground than it looks. The paper, by Shiwa Yaghoubi Bina, Steve Njokuocha and the T1D Economic Evidence Synthesis Group, has been accepted for Value in Health. The version available now is a pre-proof, so figures could still change at copyediting. The World Health Organization funded […]
Clinical Practice
Denosumab Ascend Biosimilar Wins EU Authorisation for Bone Complications
The EMA has authorised Denosumab Ascend, a biosimilar of Xgeva. Here is what the assessment shows on safety, efficacy and use. #SyenzaNews #biotechnology #MarketAccess
Europe
Health Security in Europe: Why Resilience Starts Before a Crisis
Health security in Europe is being redefined from emergency response to national resilience, and the EFPIA View argues it starts with funded health systems.
Health Policy
Health Investment Returns: What Berlin’s Funding the Future Panel Argued
Ministers, development banks and industry at the World Health Summit argued that health investment returns should be measured in lives saved, jobs and tax revenue, not budget size. #SyenzaNews #HealthEconomics #MarketAccess
Clinical Guidelines And Protocols
Individualised Genetic Therapies Test Regulation, Payment and HTA
OHE’s A Dose of Economics explores why medicines made for one patient challenge regulation, payment and HTA.
Europe
The Strategic Health Economy: Why Finance Ministries Still See Health as a Cost
At the World Health Summit in Berlin, speakers from the European Commission, Japan, Africa, the Asian Development Bank and industry argued that health is a strategic economic asset, and asked how to persuade finance ministries. #SyenzaNews #HealthEconomics
Artificial Intelligence And Machine Learning
AI in Medical Education: Responsible Integration Across the Training Continuum
AI is entering every stage of medical training. A new npj Digital Medicine Perspective maps how to integrate it responsibly across UGME, GME and CME.
Diseases
Multiple Sclerosis Health Utilities Decline With Disability
Health utilities for multiple sclerosis fall with disability, and progressive forms score lowest. A UK cohort of 5,772 patients gives modellers EQ-5D and cost inputs by MS type and EDSS band. #SyenzaNews #MarketAccess
Value Science Weekly
The week in health technology assessment, market access and health economics — what moved, and what it means.
